Breast Biopsy Devices Market
Updated Date: 17 July 2026   |   Report Code: 6810
sales@towardshealthcare.com +1 804-441-9344
Download Sample Order Now

Breast Biopsy Devices Market Size, Demand, and Trends Analysis 2035

According to Payal Rabde, who specializes in vacuum-assisted breast biopsy systesm, image-guided breast biopsy devices, and MRI-guided breast biopsy systems, with 4+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunities in the breast biopsy devices market. The global breast biopsy devices market size was estimated at USD 6.52 billion in 2025 and is predicted to increase from USD 7.03 billion in 2026 to approximately USD 13.82 billion by 2035, expanding at a CAGR of 7.8% from 2026 to 2035. Her analysis highlights the increasing adoption of stereotactic image-guided biopsy systems, digital breast tomosynthesis-guided biopsy, AI-assisted breast imaging and biopsy, automated cire needle biopsy devices, and precision breast cancer diagnostic technologies. The research also examines the competitive strategies of key industry participants, including Mammatome, BD, Hologic, Inc., Cook Medical, Argon Medical Devices, Meril Medical Systems, SteryLab, and INRAD, shaping the future by personalized breast cancer diagnostics through precision pathology, minimally invasive tissue sampling technologies, digital pathology and cloud-based diagnostic workflows, high-precision image-guided biopsy techniques, automation in biopsy device operation and specimen handling, and smart, connected breast diagnostic ecosystems in the global breast biopsy devices market.

Last Updated : 17 July 2026 Category: Medical Devices Insight Code: 6810 Format: PDF / PPT / Excel

Content

Chapter 1: Introduction

  • Market Definition & Taxonomy
  • Research Objectives
  • Market Scope & Assumptions
  • Study Timeline (Historical, Base Year, Forecast Period)
  • Key Stakeholders Covered

Chapter 2: Research Methodology

  • Research Framework Overview
  • Market Size Estimation Methodology
    • Bottom-Up Approach
    • Top-Down Approach
  • Forecasting Model
    • Dependent Variables
    • Independent Variables
    • Key Assumptions & Weightages
  • Primary Research Insights
  • Secondary Data Sources
  • Data Validation & Triangulation

Chapter 3: Executive Summary

  • Global & Regional Overview (Value, CAGR)
  • Epidemiology Snapshot
  • Segmental Overview
  • Competition Key Snippets
  • Strategic Takeaways

Chapter 4: Market Catalysts, Constraints & Growth Levers

  • Market Dynamics
  • Market Drivers/Catalysts
    • Driver 1
    • Driver 2
  • Market Restraints
    • Restraint 1
    • Restraint 2
  • Market Opportunities
    • Opportunity 1
    • Opportunity 2
  • Market Trends
    • Trend 1
    • Trend 2
  • Impact Assessment of Drivers, Restraints, Opportunities & Trends (High, Mid, & Low)

Chapter 5: Value Added Intelligence

  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers: Low/Moderate/High
    • Bargaining Power of Buyers: Low/Moderate/High
    • Threat of New Entrants: Low/Moderate/High
    • Threat of Substitute: Low/Moderate/High
    • Competitive Rivalry: Low/Moderate/High
  • PESTEL Analysis
  • Ecosystem Analysis
  • Mapping of Key Players
  • Value Chain Analysis
  • Margin Analysis Across Value Chain
  • Macro & Micro Factors Impacting Market
  • Market Potential Evaluation, By Region
  • Epidemiology & Patient Pool Analysis
    • Disease Incidence & Prevalence
    • Target Patient Pool
      • Diagnosed Population
      • Service-Seeking Population
    • Patient Flow & Utilization Analysis
      • Patient Footfall
      • Admission Rates
      • Procedure Volume
    • Healthcare Infrastructure Analysis
      • Number of Facilities
        • Hospitals
        • Clinics
        • Diagnostic Centers
        • ASCs
      • Bed Capacity
        • Total Beds
        • ICU Beds
      • Facility Distribution
    • Operational Metrics Analysis
      • Bed Occupancy Rate (%)
      • Average Length of Stay (ALOS)
    • Service Pricing & Revenue Model
      • Pricing Analysis
        • Cost per Procedure
        • Cost per Consultation
        • Cost per Diagnostic Test
      • Revenue Streams
        • Inpatient Services
        • Outpatient Services
        • Ancillary Services
      • Workforce & Staffing Analysis
        • Healthcare Workforce
          • Physicians
          • Nurses
          • Technicians
        • Staff-to-Patient Ratios
        • Skill Gap Analysis
        • Labor Cost Structure
      • Scenario Analysis (Base / Optimistic / Pessimistic)
      • Risk Assessment & Sensitivity Analysis
      • Opportunity Analysis, By Region
      • Regulatory Analysis
      • Sustainability & ESG Insights
      • Business Models
      • Investment & Funding Landscape
      • Key Conferences and Events

Chapter 7: Segmental & Regional Analysis

  • Global Breast Biopsy Devices Market Analysis, By Product Type
    • Market Size, Forecast & CAGR, By Product Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • Global Breast Biopsy Devices Market Analysis, By Technique
    • Market Size, Forecast & CAGR, By Product Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • Global Breast Biopsy Devices Market Analysis, By Imaging Modality
    • Market Size, Forecast & CAGR, By Product Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • Global Breast Biopsy Devices Market Analysis, By End User
    • Market Size, Forecast & CAGR, By Product Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • Global Breast Biopsy Devices Market Analysis, By Application
    • Market Size, Forecast & CAGR, By Product Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • Global Breast Biopsy Devices Market Analysis, By Region
    • Market Size, Forecast & CAGR, By Product Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America Breast Biopsy Devices Market Analysis
  • North America Breast Biopsy Devices Market Analysis, By Product Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America Breast Biopsy Devices Market Analysis, By Technique, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America Breast Biopsy Devices Market Analysis, By Imaging Modality, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America Breast Biopsy Devices Market Analysis, By End User, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America Breast Biopsy Devices Market Analysis, By Application, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America Breast Biopsy Devices Market Analysis, By Country, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
      • U.S. Breast Biopsy Devices Market Analysis
    • U.S. Breast Biopsy Devices Market Analysis, By Product Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
    • U.S. Breast Biopsy Devices Market Analysis, By Technique, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
    • U.S. Breast Biopsy Devices Market Analysis, By Imaging Modality, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
    • U.S. Breast Biopsy Devices Market Analysis, By End User, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
    • U.S. Breast Biopsy Devices Market Analysis, By Application, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis

Similar Analysis will be given for each country and each region

  • Canada
  • Mexico
  • Rest of North America

Europe

  • Western Europe
  • Germany
  • Italy
  • France
  • Spain
  • UK
  • Netherlands
  • Switzerland
  • Nordic Countries
  • Rest of Western Europe
  • Eastern Europe
  • Austria
  • Russia & Belarus
  • Poland
  • Türkiye
  • Rest of Eastern Europe

Asia Pacific

  • China
  • Taiwan
  • India
  • Japan
  • Vietnam
  • Australia and New Zealand
  • ASEAN Countries
  • South Korea
  • Rest of APAC

South America

  • Brazil
  • Argentina
  • Rest of South America

Middle East and Africa (MEA)

  • GCC Countries
  • South Africa
  • Egypt
  • Rest of MEA

Chapter 6: Competitive Insights

  • Competitive Analysis
    • Company Evaluation Matrix
      • Major Players
      • Mid-Sized Companies
      • Emerging Players/Start-Ups
    • Global Market Share Analysis, By Region, 2025 (%)
    • Key Player Positioning
    • Competitive Benchmarking
      • By Segment 1
      • By Segment 2
      • By Segment 3
    • Strategies of Key Players
    • Insight From the Horse’s Mouth
  • Company Profiles
    • Hologic, Inc.
      • Company Name
      • Company Headquarters
      • Management Overview
        • Key C-Suite Executives
          • CEO
          • MD
          • Others
        • Employee Count
        • Business Strategy
          • Key Investments Made
          • Future Plans
          • R&D & Innovation Capabilities
          • Recent Developments
            • New Product Launch
            • Merger & Acquisitions
            • Partnerships & Collaborations
            • Market Expansion
            • Others
          • Service Portfolio
          • Facility Network
            • Number of Facilities
            • Bed Capacity
            • Facility Distribution
            • Expansion Pipeline
          • Key Financials (2022-2025)
            • Revenue By Segment
            • Revenue By Service
            • Revenue By Geography
            • Financial Matrix (Gross Profit Margins, Net Margins, etc.)
          • Key Clients
            • Client Company Name
            • Key Contact Person
            • Contact Details
          • Regulatory & Certification Expertise
          • SWOT Analysis
    • Becton, Dickinson and Company (BD)
    • Danaher Corporation (Leica Biosystems)
    • Devicor Medical Products, Inc.
    • Merit Medical Systems
    • GE HealthCare
    • Cook Medical
    • Trivitron Healthcare
    • Siemens Healthineers
    • Fujifilm Healthcare

FAQ's

Answer : The  breast biopsy devices market in 2026 is valued at USD 7.03 billion and is projected to climb to USD 13.82 billion by 2035, with a CAGR of 7.8% over the forecast period.

Answer : North America is currently leading the breast biopsy devices market by 38% due to the presence of advanced healthcare infrastructure & vast demand for minimally invasive procedures. 

Answer : US FDA, NIH, ESIC, MedlinePlus.gov, CMS, NCI, CDC, ClinicalTrials.gov, ICMR, WHO, etc.
Any Questions

Meet the Team

Payal Rabde is a Healthcare Market Research Analyst at Towards Healthcare Research & Consulting with 4+ years of experience in pharmaceuticals, biotechnology, medical devices, and life sciences.

Learn more about Payal Rabde

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar